Results 41 to 50 of about 13,238 (216)

Reactogenicity to COVID-19 vaccination in the United States of America

open access: yesClinical and Experimental Vaccine Research, 2022
In the United States, Pfizer-BioNTech, Moderna, and Janssen's coronavirus disease 2019 (COVID-19) vaccines have been granted Emergency Use Authorization (EUA) with the Pfizer-BioNTech vaccine presently approved by the US Food and Drug Administration. The purpose of this study is to analyze passive surveillance data on COVID-19 vaccine adverse reaction ...
Adekunle Sanyaolu   +11 more
openaire   +2 more sources

Summary of solicited reactogenicity.

open access: yes, 2018
Summary of solicited reactogenicity.
Myeisha Paskel (5925674)   +18 more
core   +1 more source

Pneumococcal conjugate 7-valent vacciPNEUMOCOCCAL CONJUGATE 7-VALENT VACCINE IN CHILDREN. REGIONAL EXPERIENCEne in children. Regional experience

open access: yesПедиатрическая фармакология, 2012
Paper is devoted to one of the most actual problems of early childhood — a pneumococcal infection. The unique preventive way is vaccination. The authors have demonstrated their own experience with pneumococcal conjugate 7-valent vaccine in 196 children 1–
N. L. Chernaya   +5 more
doaj   +1 more source

MPL Adjuvant Contains Competitive Antagonists of Human TLR4

open access: yesFrontiers in Immunology, 2020
Monophosphoryl lipid A (MPL®) is the first non-alum vaccine adjuvant to achieve widespread clinical and market acceptance, a remarkable achievement given that it is manufactured from a Salmonella enterica endotoxin.
Yi-Qi Wang   +4 more
doaj   +1 more source

Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV

open access: yesAIDS, 2023
Objective: To evaluate immunogenicity and reactogenicity of yellow fever (YF) vaccine in people with HIV (PWH) compared to HIV-uninfected controls. Design: In this longitudinal interventional trial (NCT03132311), PWH with CD4+ cell count ≥200 cells/μl and controls, aged 18–59 ...
Motta, Edwiges   +18 more
openaire   +2 more sources

Guinea pig reactogenicity model.

open access: yes, 2018
Guinea pig reactogenicity model.
Richard A. Bowen (221292)   +5 more
core   +1 more source

Maximum Local Reactogenicity Summary for All Vaccinations.

open access: yes, 2014
Maximum Local Reactogenicity Summary for All Vaccinations.
Julie E. Ledgerwood (253787)   +11 more
core   +1 more source

Study of Anaphylactogenic Properties of F(ab')2-Fragments of Heterologous Anti-Rabies Immunoglobulin

open access: yesПроблемы особо опасных инфекций, 2009
Anaphylactogenic properties of heterologous anti-rabies immunoglobulin and its F(ab')2-fragments were tested in vivo. It was shown that F(ab')2-fragments of heterologous anti-rabies immunoglobulin did not possess anaphylactogenic properties.
S.V. Generalov   +11 more
doaj   +1 more source

Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability

open access: yesFrontiers in Immunology, 2023
IntroductionNatural killer (NK) cells can both amplify and regulate immune responses to vaccination. Studies in humans and animals have observed NK cell activation within days after mRNA vaccination.
Elizabeth K. Graydon   +51 more
doaj   +1 more source

Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults

open access: yesThe Journal of Infectious Diseases, 2020
Abstract Background We analyzed data from a randomized controlled trial on the reactogenicity of 3 enhanced influenza vaccines compared with standard-dose (SD) inactivated influenza vaccine. Methods We enrolled community-dwelling ...
Benjamin J, Cowling   +9 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy